Carcinoid tumor belongs to neuroendocrine tumors with low incidence. When carcinoid syndrome is present, suspicion for this disease is very high. In other cases the symptomatology is nonspecific. Localisation of the primary tumor is often difficult. In the therapy surgical resection and debulking therapy dominates and in the present of carcinoid syndrome therapy with somatostatine analogues and interferone alfa is predominant.